TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Moderators and Mediators of Physical Activity, Body Weight, and Body Composition Change During Obesity Treatment in Women
Brief Summary: The primary objectives of this randomized clinical trial are a) to implement and test the impact of a 1-year lifestyle obesity treatment program based on Self-Determination Theory on 3-year change in physical activity and motivation for exercise/physical activity, body weight and fat, and selected eating variables, b) to identify behavioral and psychosocial theory-based moderators or mediators of primary outcomes, especially physical activity and body weight.


Options:
A: Arm Label: SDT Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SDT and Motivational Interviewing in Obesity Treatment | Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SDT and Motivational Interviewing in Obesity Treatment; Assigned to Arm(s): SDT Intervention
B: Arm Label: Case-Management for Behavior Change; Type: EXPERIMENTAL; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Arm Label: Case-Management plus Home Visits; Type: EXPERIMENTAL; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Arm Label: Usual Primary Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Vivamos Activos Fair Oaks Program | Intervention Type: BEHAVIORAL; Name: Vivamos Activos Fair Oaks Program; Assigned to Arm(s): Case-Management for Behavior Change, Case-Management plus Home Visits, Usual Primary Care
C: Arm Label: Lifestyle, follow-up, early care, standard care high/low risk; Type: OTHER; Interventions: Behavioral: Lifestyle: diet and exercise | Arm Label: Close follow-up; Type: OTHER; Interventions: Behavioral: Close follow-up: reporting diaries of food and exercise | Intervention Type: BEHAVIORAL; Name: Lifestyle: diet and exercise; Assigned to Arm(s): Lifestyle, follow-up, early care, standard care high/low risk | Intervention Type: BEHAVIORAL; Name: Close follow-up: reporting diaries of food and exercise; Assigned to Arm(s): Close follow-up
D: Arm Label: Lifestyle counseling; Type: EXPERIMENTAL; Interventions: Behavioral: moderate exercise and healthy, low-fat diet | Intervention Type: BEHAVIORAL; Name: moderate exercise and healthy, low-fat diet; Assigned to Arm(s): Lifestyle counseling

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zambia Integrated Management of Malaria and Pneumonia Study
Brief Summary: The purpose of the study is to demonstrate the effectiveness and feasibility of community-based management of pneumonia and malaria by community health workers (CHWs) in a rural district of Zambia.


Options:
A: Arm Label: Current Practice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Arm; Type: ACTIVE_COMPARATOR; Interventions: Device: Malaria Rapid Diagnostic test | Intervention Type: DEVICE; Name: Malaria Rapid Diagnostic test; Assigned to Arm(s): Intervention Arm
B: Arm Label: Training of VHVs in iCCM; Type: EXPERIMENTAL; Interventions: Other: Training of VHVs in iCCM | Intervention Type: OTHER; Name: Training of VHVs in iCCM; Assigned to Arm(s): Training of VHVs in iCCM
C: Arm Label: ICCM delivered by VHT; Type: ACTIVE_COMPARATOR; Interventions: Other: ICCM delivered by VHT | Arm Label: ICCM delivered by VHT with cell phone; Type: ACTIVE_COMPARATOR; Interventions: Other: ICCM delivered by VHT, Other: ICCM delivered by VHT with Cell Phone | Arm Label: Health outcomes in communities with no ICCM; Type: ACTIVE_COMPARATOR; Interventions: Other: No intervention | Intervention Type: OTHER; Name: ICCM delivered by VHT; Assigned to Arm(s): ICCM delivered by VHT, ICCM delivered by VHT with cell phone | Intervention Type: OTHER; Name: ICCM delivered by VHT with Cell Phone; Assigned to Arm(s): ICCM delivered by VHT with cell phone | Intervention Type: OTHER; Name: No intervention; Assigned to Arm(s): Health outcomes in communities with no ICCM
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zambia Integrated Management of Malaria and Pneumonia Study
Brief Summary: The purpose of the study is to demonstrate the effectiveness and feasibility of community-based management of pneumonia and malaria by community health workers (CHWs) in a rural district of Zambia.


Options:
A: Intervention Type: DEVICE; Name: Rapid diagnostic test for malaria; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Rapid diagnostic test for malaria | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: Rapid diagnostic test for malaria | Intervention Type: DEVICE; Name: Rapid diagnostic test for malaria; Assigned to Arm(s): 1, 2
D: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Microscopy | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Clinical diagnosis for malaria | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Rapid diagnostic test | Intervention Type: PROCEDURE; Name: Rapid diagnostic test; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Microscopy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Clinical diagnosis for malaria; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zambia Integrated Management of Malaria and Pneumonia Study
Brief Summary: The purpose of the study is to demonstrate the effectiveness and feasibility of community-based management of pneumonia and malaria by community health workers (CHWs) in a rural district of Zambia.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: IMNCI | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IMNCI; Assigned to Arm(s): 1
C: Arm Label: nothing at home level; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home management of malaria; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Arm Label: Home management of malaria and pneumonia; Type: EXPERIMENTAL; Interventions: Other: home/community case management | Intervention Type: OTHER; Name: home/community case management; Assigned to Arm(s): Home management of malaria, Home management of malaria and pneumonia
D: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: Neonatal resuscitation protocol | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: Neonatal resuscitation protocol; Assigned to Arm(s): intervention | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zambia Integrated Management of Malaria and Pneumonia Study
Brief Summary: The purpose of the study is to demonstrate the effectiveness and feasibility of community-based management of pneumonia and malaria by community health workers (CHWs) in a rural district of Zambia.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2
B: Arm Label: Arm1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Community Based | Intervention Type: OTHER; Name: Community Based; Assigned to Arm(s): 2
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: IMNCI | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: IMNCI; Assigned to Arm(s): 1
D: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: Neonatal resuscitation protocol | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard of care | Intervention Type: OTHER; Name: Neonatal resuscitation protocol; Assigned to Arm(s): intervention | Intervention Type: OTHER; Name: Standard of care; Assigned to Arm(s): control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zambia Integrated Management of Malaria and Pneumonia Study
Brief Summary: The purpose of the study is to demonstrate the effectiveness and feasibility of community-based management of pneumonia and malaria by community health workers (CHWs) in a rural district of Zambia.


Options:
A: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Microscopy | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Clinical diagnosis for malaria | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Rapid diagnostic test | Intervention Type: PROCEDURE; Name: Rapid diagnostic test; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Microscopy; Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Clinical diagnosis for malaria; Assigned to Arm(s): 3
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Coartem and amoxicillin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Coartem | Intervention Type: DRUG; Name: Coartem and amoxicillin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Coartem; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: artemether-lumefantrine; Assigned to Arm(s): N/A
D: Arm Label: SP and amodiaquine; Type: ACTIVE_COMPARATOR; Interventions: Drug: SP plus amodiaquine | Arm Label: SP placebo plus amodiaquine placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: SP placebo plus amodiaquine placebo | Intervention Type: DRUG; Name: SP plus amodiaquine; Assigned to Arm(s): SP and amodiaquine | Intervention Type: DRUG; Name: SP placebo plus amodiaquine placebo; Assigned to Arm(s): SP placebo plus amodiaquine placebo

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Arginine Supplementation in Sickle Cell Anemia: Physiological and Prophylactic Effects
Brief Summary: Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited genetic disease that can cause intense pain episodes. This study will evaluate the effectiveness of the nutritional supplement arginine at improving blood cell function and disease symptoms in people with SCD.


Options:
A: Arm Label: L-Arginine; Type: EXPERIMENTAL; Interventions: Drug: L-arginine | Arm Label: Loading Dose and L-Arginine; Type: EXPERIMENTAL; Interventions: Drug: L-arginine, Drug: L-arginine Loading Dose | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: L-arginine; Assigned to Arm(s): L-Arginine, Loading Dose and L-Arginine | Intervention Type: DRUG; Name: L-arginine Loading Dose; Assigned to Arm(s): Loading Dose and L-Arginine | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Low Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Arginine | Arm Label: High Dose; Type: ACTIVE_COMPARATOR; Interventions: Drug: Arginine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Arginine; Assigned to Arm(s): High Dose, Low Dose | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: L-Arginine Hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: L-Arginine Hydrochloride | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal saline | Intervention Type: DRUG; Name: L-Arginine Hydrochloride; Assigned to Arm(s): L-Arginine Hydrochloride | Intervention Type: OTHER; Name: Normal saline; Assigned to Arm(s): Placebo
D: Arm Label: LOVAZA; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Omega-3 Fatty Acids: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) | Arm Label: Placebo capsule; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo Capsules | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fatty Acids: Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA); Assigned to Arm(s): LOVAZA | Intervention Type: OTHER; Name: Placebo Capsules; Assigned to Arm(s): Placebo capsule

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 4 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
Brief Summary: The purpose of this study is to explore the recurrence risk of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease after different antidiabetic drug therapy (glipizide or metformin) by using an double-blind, randomized, parallel control and prospective study

The end point of this study is:

1. follow up 3yr
2. recurrence of cardiovascular event
3. death caused by other reasons such as stroke, uremia, blindness and amputation


Options:
A: Intervention Type: DRUG; Name: vildagliptin; Assigned to Arm(s): N/A
B: Arm Label: metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glipizide | Arm Label: glipizide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Intervention Type: DRUG; Name: Glipizide; Assigned to Arm(s): metformin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): glipizide
C: Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: Vildagliptin; Type: EXPERIMENTAL; Interventions: Drug: Vildagliptin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Vildagliptin; Assigned to Arm(s): Vildagliptin
D: Intervention Type: DRUG; Name: Rosiglitazone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: glyburide; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: metformin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 4 Study on the Prognosis and Effect of Anti-diabetic Drugs on Type-2 Diabetes Mellitus With Coronary Artery Disease
Brief Summary: The purpose of this study is to explore the recurrence risk of cardiovascular events in patients with type 2 diabetes mellitus and coronary heart disease after different antidiabetic drug therapy (glipizide or metformin) by using an double-blind, randomized, parallel control and prospective study

The end point of this study is:

1. follow up 3yr
2. recurrence of cardiovascular event
3. death caused by other reasons such as stroke, uremia, blindness and amputation


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Arm Label: Intensive Lifestyle; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive lifestyle | Intervention Type: BEHAVIORAL; Name: Intensive lifestyle; Assigned to Arm(s): Intensive Lifestyle | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Liraglutide; Type: EXPERIMENTAL; Interventions: Drug: liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Liraglutide | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Arm Label: Lira 1.8 mg; Type: EXPERIMENTAL; Interventions: Drug: liraglutide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: liraglutide; Assigned to Arm(s): Lira 1.8 mg | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
D: Arm Label: metformin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Glipizide | Arm Label: glipizide; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metformin | Intervention Type: DRUG; Name: Glipizide; Assigned to Arm(s): metformin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): glipizide

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain
Brief Summary: The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".


Options:
A: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
B: Arm Label: Methylnaltrexone bromide; Type: EXPERIMENTAL; Interventions: Drug: Methylnaltrexone bromide | Intervention Type: DRUG; Name: Methylnaltrexone bromide; Assigned to Arm(s): Methylnaltrexone bromide
C: Arm Label: Targinact® (oxycodon/naloxon); Type: N/A; Interventions: Drug: Targinact® (oxycodon/naloxon) | Intervention Type: DRUG; Name: Targinact® (oxycodon/naloxon); Assigned to Arm(s): Targinact® (oxycodon/naloxon)
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: SC Placebo | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SC Placebo; Assigned to Arm(s): Arm 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain
Brief Summary: The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".


Options:
A: Arm Label: The LCP-I Program.; Type: EXPERIMENTAL; Interventions: Other: The LCP-I Program | Arm Label: standard healthcare practices; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: The LCP-I Program; Assigned to Arm(s): The LCP-I Program.
B: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
C: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: R331333 (referred to as JNS024 ER or CG5503) | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone CR | Intervention Type: DRUG; Name: Oxycodone CR; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: R331333 (referred to as JNS024 ER or CG5503); Assigned to Arm(s): 001
D: Arm Label: carboplatin + etoposide + exisulind; Type: EXPERIMENTAL; Interventions: Drug: carboplatin, Drug: etoposide, Drug: exisulind | Intervention Type: DRUG; Name: carboplatin; Assigned to Arm(s): carboplatin + etoposide + exisulind | Intervention Type: DRUG; Name: etoposide; Assigned to Arm(s): carboplatin + etoposide + exisulind | Intervention Type: DRUG; Name: exisulind; Assigned to Arm(s): carboplatin + etoposide + exisulind

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain
Brief Summary: The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".


Options:
A: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
B: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Arm Label: Arm 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: SC Placebo | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Drug: SC Methylnaltrexone | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: SC Placebo; Assigned to Arm(s): Arm 3 | Intervention Type: DRUG; Name: SC Methylnaltrexone; Assigned to Arm(s): Arm 2
C: Arm Label: Methylnaltrexone bromide; Type: EXPERIMENTAL; Interventions: Drug: Methylnaltrexone bromide | Intervention Type: DRUG; Name: Methylnaltrexone bromide; Assigned to Arm(s): Methylnaltrexone bromide
D: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised, Double-blind, Active-controlled, Double-dummy, Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Cancer Pain
Brief Summary: The purpose of this study is to test the oxycodone/naloxone combination compared to oxycodone alone in patient's specific type of "chronic cancer pain".


Options:
A: Arm Label: Oxycodone Hydrochloride; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone Hydrochloride | Arm Label: Morphine Sulphate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Morphine Sulphate | Intervention Type: DRUG; Name: Oxycodone Hydrochloride; Assigned to Arm(s): Oxycodone Hydrochloride | Intervention Type: DRUG; Name: Morphine Sulphate; Assigned to Arm(s): Morphine Sulphate
B: Arm Label: 001; Type: EXPERIMENTAL; Interventions: Drug: R331333 (referred to as JNS024 ER or CG5503) | Arm Label: 002; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone CR | Intervention Type: DRUG; Name: Oxycodone CR; Assigned to Arm(s): 002 | Intervention Type: DRUG; Name: R331333 (referred to as JNS024 ER or CG5503); Assigned to Arm(s): 001
C: Arm Label: Oxycodone Hydrochloride Tablets; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxycodone | Arm Label: Oxycodone Naloxone Tablets; Type: EXPERIMENTAL; Interventions: Drug: Oxycodone/Naloxone | Intervention Type: DRUG; Name: Oxycodone; Assigned to Arm(s): Oxycodone Hydrochloride Tablets | Intervention Type: DRUG; Name: Oxycodone/Naloxone; Assigned to Arm(s): Oxycodone Naloxone Tablets
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: oxycodone, Drug: pregabalin | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxycodone, Drug: pregabalin | Intervention Type: DRUG; Name: oxycodone; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): A, B

Answer: C